One Nucleus announces new director
Industry expert to support life sciences membership group
Palmer has close ties with the London life science and healthcare community and was a strong supporter of the London Biotechnology Network (LBN), which is now part of One Nucleus.
Commenting on his appointment, Palmer said: “I have worked with Harriet Fear and Tony Jones for many years and am very excited about the merger of ERBI and LBN to form One Nucleus. These are challenging times and One Nucleus is extremely well placed to support the biotechnology sector.’
Harriet Fear, ceo of One Nucleus, added: ‘Alan is a great addition to the team. He has a deep understanding of the needs of One Nucleus members, and this coupled with his academic and pharma background makes him an ideal director for One Nucleus.’
You may also like
Media
ACG wins Red Dot Design Award for breakthrough Personalised Medicine Concept
ACG’s Personalised Medicine Concept (PMC) has earned the Red Dot Award for high design quality, recognising its pioneering approach to capsule-based personalised health solutions developed through the collaborative OneACG ecosystem